Atrás
Precio Ascentage Pharma Group International (ASPHF)
Gráfico del Precio de Acciones ASPHF
ASPHF Ganando
Ascentage Pharma Group International
$0
0%
$0
Al cierre: Jan 23, 16:00:00 GMT-5
$0
0%
$0
Mercado Posterior: Jan 23, 16:20:35 GMT-5
Estadísticas clave
Cierre Anterior
$8.48
Precio de apertura
--
Rango del día
-
Rango de 52 semanas
-
Volumen
--
Volumen promedio
58
EPS (TTM)
-0.52
Rendimiento de dividendos
--
Cap. de mercado
--
¿Qué es ASCENTAGE PHARMA GROUP INTL?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved